speb/financial-data huggingface dataset:
ICHR balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 10602000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 10602000.00
ICHR income_statement (annual, 2025-12-31) — Other Income Expense: -1674000.00
ICHR income_statement (quarterly, 2025-12-31) — Other Income Expense: -308000.00
ICHR balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 40406000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 40406000.00
ICHR cash_flow (annual, 2025-12-31) — Other Non Cash Items: 426000.00
ICHR cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 77000.00
ICHR balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 13638000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 13638000.00
ICHR balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 4753000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 4753000.00
ICHR income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -1674000.00
ICHR income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -308000.00
ICHR balance_sheet (annual, 2025-12-31) — Other Properties: 35046000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Other Properties: 35046000.00
ICHR balance_sheet (annual, 2025-12-31) — Payables: 84007000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Payables: 84007000.00
ICHR balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 101486000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 101486000.00
ICHR balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
ICHR balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
ICHR income_statement (annual, 2025-12-31) — Pretax Income: -47566000.00
ICHR income_statement (quarterly, 2025-12-31) — Pretax Income: -15829000.00
ICHR cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 5628000.00
ICHR cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 356000.00
ICHR balance_sheet (annual, 2025-12-31) — Properties: 0.00
ICHR balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ICHR balance_sheet (annual, 2025-12-31) — Raw Materials: 204166000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Raw Materials: 204166000.00
ICHR balance_sheet (annual, 2025-12-31) — Receivables: 70514000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Receivables: 70514000.00
ICHR income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 834683000.00
ICHR income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 194658000.00
ICHR income_statement (annual, 2025-12-31) — Reconciled Depreciation: 33505000.00
ICHR income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 10044000.00
ICHR cash_flow (annual, 2025-12-31) — Repayment Of Debt: -61378000.00
ICHR cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
ICHR income_statement (annual, 2025-12-31) — Research And Development: 23086000.00
ICHR income_statement (quarterly, 2025-12-31) — Research And Development: 5604000.00
ICHR balance_sheet (annual, 2025-12-31) — Retained Earnings: 131070000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 131070000.00
ICHR income_statement (annual, 2025-12-31) — Selling General And Administration: 95650000.00
ICHR income_statement (quarterly, 2025-12-31) — Selling General And Administration: 27135000.00
ICHR balance_sheet (annual, 2025-12-31) — Share Issued: 38871215.00
ICHR balance_sheet (quarterly, 2025-12-31) — Share Issued: 38871215.00
ICHR cash_flow (annual, 2025-12-31) — Stock Based Compensation: 16728000.00
ICHR cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 4157000.00
ICHR balance_sheet (annual, 2025-12-31) — Stockholders Equity: 663886000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 663886000.00
ICHR balance_sheet (annual, 2025-12-31) — Tangible Book Value: 288078000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 288078000.00
ICHR income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ICHR income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ICHR income_statement (annual, 2025-12-31) — Tax Provision: 5215000.00
ICHR income_statement (quarterly, 2025-12-31) — Tax Provision: 132000.00
ICHR income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.17
ICHR income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.17
ICHR balance_sheet (annual, 2025-12-31) — Total Assets: 942879000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Total Assets: 942879000.00
ICHR balance_sheet (annual, 2025-12-31) — Total Capitalization: 781164000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 781164000.00
ICHR balance_sheet (annual, 2025-12-31) — Total Debt: 160191000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Total Debt: 160191000.00
ICHR balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 663886000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 663886000.00
ICHR income_statement (annual, 2025-12-31) — Total Expenses: 986924000.00
ICHR income_statement (quarterly, 2025-12-31) — Total Expenses: 237441000.00
ICHR balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 278993000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 278993000.00
ICHR balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 532751000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 532751000.00
ICHR balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 149405000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 149405000.00
ICHR income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -39272000.00
ICHR income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -13835000.00
ICHR balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 4437439.00
ICHR balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 4437439.00
ICHR balance_sheet (annual, 2025-12-31) — Treasury Stock: 91578000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 91578000.00
ICHR balance_sheet (annual, 2025-12-31) — Work In Process: 39595000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Work In Process: 39595000.00
ICHR balance_sheet (annual, 2025-12-31) — Working Capital: 280541000.00
ICHR balance_sheet (quarterly, 2025-12-31) — Working Capital: 280541000.00
ICHR income_statement (quarterly, 2026-03-31) — +Operating Expense: 30173000.00
ICHR income_statement (quarterly, 2026-03-31) — +Total Revenue: 256068000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 108175000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 93067000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -123841000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 630988000.00
ICHR income_statement (quarterly, 2026-03-31) — Amortization: 2078000.00
ICHR income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 2078000.00
ICHR income_statement (quarterly, 2026-03-31) — Basic Average Shares: 34607033.00
ICHR income_statement (quarterly, 2026-03-31) — Basic EPS: -0.07
ICHR cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 98290000.00
ICHR cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -7065000.00
ICHR cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -7065000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 36622000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Capital Stock: 3000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 89089000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 89089000.00
ICHR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 781000.00
ICHR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -7065000.00
ICHR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -2917000.00
ICHR cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 27382000.00
ICHR cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -531000.00
ICHR cash_flow (quarterly, 2026-03-31) — Change In Inventory: -20505000.00
ICHR cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 673000.00
ICHR cash_flow (quarterly, 2026-03-31) — Change In Payable: 27382000.00
ICHR cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 26851000.00
ICHR cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 2856000.00
ICHR cash_flow (quarterly, 2026-03-31) — Change In Receivables: -22553000.00
ICHR cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -12678000.00
ICHR cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -22553000.00
ICHR cash_flow (quarterly, 2026-03-31) — Changes In Cash: -9201000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Common Stock: 3000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 668014000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 10307000.00
ICHR income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 223810000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 16528000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Current Assets: 442094000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 12203000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Current Debt: 6250000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 18453000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 156672000.00
ICHR cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 665000.00
ICHR cash_flow (quarterly, 2026-03-31) — Deferred Tax: 665000.00
ICHR cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 7654000.00
ICHR income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 2078000.00
ICHR cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 7654000.00
ICHR income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 2078000.00
ICHR income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 34607033.00
ICHR income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.07
ICHR income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -2469000.00
ICHR income_statement (quarterly, 2026-03-31) — EBIT: 1762000.00
ICHR income_statement (quarterly, 2026-03-31) — EBITDA: 9416000.00
ICHR cash_flow (quarterly, 2026-03-31) — End Cash Position: 89089000.00
ICHR cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 781000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Finished Goods: 39398000.00
ICHR cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -9982000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Goodwill: 335402000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 373729000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Gross PPE: 262518000.00
ICHR income_statement (quarterly, 2026-03-31) — Gross Profit: 32258000.00
ICHR cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 686000.00
ICHR income_statement (quarterly, 2026-03-31) — Interest Expense: 1678000.00
ICHR income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1678000.00
ICHR cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 1959000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -37511000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Inventory: 252299000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Invested Capital: 790057000.00
ICHR cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -7065000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Leases: 64920000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 24419000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 115793000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 140212000.00
ICHR cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1563000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 152165000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Net Debt: 32954000.00
ICHR income_statement (quarterly, 2026-03-31) — Net Income: -2469000.00
ICHR income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -2469000.00
ICHR income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -2469000.00
ICHR income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -2469000.00
ICHR income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -2469000.00
ICHR cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -2469000.00
ICHR income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -2469000.00
ICHR income_statement (quarterly, 2026-03-31) — Net Interest Income: -1678000.00
ICHR cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1563000.00
ICHR cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1563000.00
ICHR income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1678000.00
ICHR cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -2422000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Net PPE: 138677000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 294285000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 4338000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 2627000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 4338000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2627000.00
ICHR income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 9416000.00
ICHR income_statement (quarterly, 2026-03-31) — Normalized Income: -2469000.00
ICHR cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -2917000.00
ICHR income_statement (quarterly, 2026-03-31) — Operating Income: 2085000.00
ICHR income_statement (quarterly, 2026-03-31) — Operating Revenue: 256068000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 34744772.00
ICHR balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 7639000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 6250000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 13516000.00
ICHR income_statement (quarterly, 2026-03-31) — Other Income Expense: -323000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 38327000.00
ICHR cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 78000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 13664000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 4977000.00
ICHR income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -323000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Other Properties: 35126000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Payables: 108175000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 124703000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
ICHR income_statement (quarterly, 2026-03-31) — Pretax Income: 84000.00
ICHR cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 4766000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
ICHR balance_sheet (quarterly, 2026-03-31) — Raw Materials: 195204000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Receivables: 93067000.00
ICHR income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 218234000.00
ICHR income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 7654000.00
ICHR cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1563000.00
ICHR income_statement (quarterly, 2026-03-31) — Research And Development: 5530000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 128601000.00
ICHR income_statement (quarterly, 2026-03-31) — Selling General And Administration: 22565000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Share Issued: 39182211.00
ICHR cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 3833000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 668014000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 294285000.00
ICHR income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ICHR income_statement (quarterly, 2026-03-31) — Tax Provision: 2553000.00
ICHR income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
ICHR balance_sheet (quarterly, 2026-03-31) — Total Assets: 972502000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 783807000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Total Debt: 158665000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 668014000.00
ICHR income_statement (quarterly, 2026-03-31) — Total Expenses: 253983000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 304488000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 530408000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 147816000.00
ICHR income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 2085000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 4437439.00
ICHR balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 91578000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Work In Process: 55208000.00
ICHR balance_sheet (quarterly, 2026-03-31) — Working Capital: 285422000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — +Operating Expense: 3697200000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — +Total Revenue: 26891800000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 789600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1122700000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1592000000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 42200000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Amortization: 92100000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 92100000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 15634800000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 494258520.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Basic EPS: 30.67
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 251900000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 301400000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -410400000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 176500000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 314500000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 8087600000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -12197600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 314500000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -615300000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 343300000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Change In Payable: 92100000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -120500000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -262100000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 62600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Common Stock: 176500000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -12197600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 23130600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 48700000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 4463800000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Current Assets: 9815600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 2894300000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 77200000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Depreciation: 412900000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 505000000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 505000000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 412900000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 494258520.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Diluted EPS: 30.67
ICICIAMC.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 15157800000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 6700000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — EBIT: 20220800000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — EBITDA: 20725800000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — End Cash Position: 314500000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -12642600000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 13589200000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -1481500000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 3600000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 275400000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 194500000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 2963400000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Gross Profit: 22428000000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Interest Expense: 149100000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 149100000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Interest Income: 443800000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 443800000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -149100000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 576500000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 23130600000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1294400000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 15634800000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 0.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 59900000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 586000000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Net Income: 15157800000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 15157800000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 15157800000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 15157800000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 15157800000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 20071700000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 15157800000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Net Interest Income: 294700000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -1472500000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 294700000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Net PPE: 1371400000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -405100000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 22936100000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 397200000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 202900000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 19694600000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Normalized Income: 14379244000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 13999600000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Operating Income: 18730800000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Operating Revenue: 26891800000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 558400000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 670600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 664400000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 194500000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 198600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 633300000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 24900000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 8300000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1651800000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Other Properties: 2027300000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 2700000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 7773100000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Payables: 907800000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Pretax Income: 20071700000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -410400000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 4463800000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 505000000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 24600000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 24600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 21121100000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 5300000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 618400000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 893800000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 23130600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 22936100000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 252644000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Tax Provision: 4913900000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.25
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 44200000.00
ICICIAMC.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -5035700000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Total Assets: 28047600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 23130600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 23130600000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Total Expenses: 8161000000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 4917000000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 18232000000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 2022700000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 118200000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 1031200000.00
ICICIAMC.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 1031200000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 56600000.00
ICICIAMC.NS balance_sheet (annual, 2023-03-31) — Working Capital: 6921300000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — +Operating Expense: 4517500000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — +Total Revenue: 33759000000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1150500000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1957900000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1887000000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 42200000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Amortization: 122300000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 122300000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 19069500000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 494258520.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Basic EPS: 41.47
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 314500000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 403000000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -546100000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 176500000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 231100000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 10596700000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -14774800000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 231100000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -292300000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 506700000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Change In Payable: 395900000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -836200000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -207400000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -83400000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Common Stock: 176500000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -14774800000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 28828400000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 31700000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 5951600000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Current Assets: 13305100000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 3857400000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 117200000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Depreciation: 534800000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 657100000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 657100000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 534800000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 494258520.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Diluted EPS: 41.47
ICICIAMC.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 20497300000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 15100000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — EBIT: 27143000000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — EBITDA: 27800100000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — End Cash Position: 231100000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -15272800000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 17099300000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -3816100000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 2500000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 303000000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 308300000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 3637300000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Gross Profit: 27807400000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Interest Expense: 161900000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 161900000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Interest Income: 575400000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 575400000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -161900000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 592900000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 28828400000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -2456000000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 19069500000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 0.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 71300000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 784000000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Net Income: 20497300000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 20497300000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 20497300000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 20497300000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 20497300000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 26981100000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 20497300000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Net Interest Income: 413500000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -2520100000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 413500000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Net PPE: 1750300000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -543900000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 28520100000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 414600000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 582600000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 24566500000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Normalized Income: 18039764000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 17645400000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Operating Income: 23289900000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Operating Revenue: 33759000000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 698700000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 792800000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 664400000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 308300000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 138700000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 691200000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 21500000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 29800000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 2087500000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Other Properties: 2418600000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 2500000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 10365600000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Payables: 1303000000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Pretax Income: 26981100000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -546100000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 5951600000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 657100000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 1000000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 1000000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 26818900000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 2200000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 661100000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 964100000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 28828400000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 28520100000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 776064000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Tax Provision: 6483800000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.24
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 49300000.00
ICICIAMC.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -6084000000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Total Assets: 35540900000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 28828400000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 28828400000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Total Expenses: 10469100000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 6712500000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 22235800000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 2855100000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 152500000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 3233600000.00
ICICIAMC.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 3233600000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 65200000.00
ICICIAMC.NS balance_sheet (annual, 2024-03-31) — Working Capital: 9447700000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 1115700000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 12266600000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 494397496.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 12.78
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 2567500000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 211600000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 211600000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 494397496.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 12.78
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 6318400000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — EBIT: 8329800000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — EBITDA: 8541400000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 9699100000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 48800000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 48800000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Net Income: 6318400000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 6318400000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 6318400000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 6318400000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 6318400000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 6318400000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -48800000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -48800000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 8541400000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 6318400000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Operating Income: 8583400000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 12266600000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -253600000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 904100000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 8281000000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 2567500000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 211600000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 1962600000.00
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.24
ICICIAMC.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 3683200000.00
ICICIAMC.NS income_statement (annual, 2025-03-31) — +Operating Expense: 5815300000.00
ICICIAMC.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1680900000.00
ICICIAMC.NS income_statement (annual, 2025-03-31) — +Total Revenue: 46827800000.00
ICICIAMC.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 12691900000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1753500000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1753500000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2371900000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2371900000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1717000000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1717000000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 42200000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 42200000.00
ICICIAMC.NS income_statement (annual, 2025-03-31) — Amortization: 227600000.00
ICICIAMC.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 227600000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 17985000000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 17985000000.00
ICICIAMC.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 494300000.00
ICICIAMC.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 494431737.00
ICICIAMC.NS income_statement (annual, 2025-03-31) — Basic EPS: 53.60
ICICIAMC.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 13.99
ICICIAMC.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 231100000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 468900000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 468900000.00
ICICIAMC.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -4116200000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 176500000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 176500000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 154400000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 154400000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 15667800000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 15667800000.00
ICICIAMC.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -20123400000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 154400000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 154400000.00
ICICIAMC.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 91700000.00
ICICIAMC.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 736100000.00
ICICIAMC.NS cash_flow (annual, 2025-03-31) — Change In Payable: 537800000.00
ICICIAMC.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -414900000.00
ICICIAMC.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 961200000.00
ICICIAMC.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -76700000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Common Stock: 176500000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 176500000.00
ICICIAMC.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -20123400000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 35169400000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 35169400000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 2841400000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 2841400000.00
ICICIAMC.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 8465400000.00
ICICIAMC.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2303000000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Current Assets: 18934300000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 18934300000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 197900000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 197900000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 4986100000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4986100000.00
ICICIAMC.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 159400000.00
ICICIAMC.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 159400000.00